Sign in
ARIA Stock Price, Chart, Stats & News
ARIA Opportunities ETF
Save
ARIA Opportunities ETF (ARIA) does not currently pay a dividend.
Global Large-Stock Blend
Category
0.72%
Expense ratio
12.75M
Assets
ARIA chart
ARIA returns
| 1Y volatility | 0.00% |
| 3Y volatility | 0.00% |
| Sharpe ratio | 0.00 |
About
ARIAD Pharmaceuticals, Inc. operates as a global oncology firm, dedicated to the identification, advancement, and commercialization of innovative therapies. Its core mission is to significantly improve the lives of those affected by cancer. Leveraging an innovative methodology grounded in structure-based drug design, the company has successfully pioneered numerous precision-targeted treatments, particularly addressing malignancies that are resistant to existing therapies or are inherently challenging to manage.
Top 10 ARIA holdings
| Holding | Ownership |
|---|---|
Technology 28.89% | |
Industrials 4.55% | |
Technology 4.13% | |
Consumer Cyclical 3.60% | |
Consumer Cyclical 3.50% | |
Consumer Cyclical 3.38% | |
Communication Services 3.35% | |
Financial Services 3.24% | |
Financial Services 3.03% | |
Technology 2.97% |
Similar securities
Based on sector and market capitalization
Report issue